APO Research
Talk to an analyst

APO RESEARCH · REPORT

Post-Traumatic Stress Disorder (PTSD) Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025171 pages

Choose your research edition.

Industry ResearchPost-Traumatic Stress Disorder (PTSD) Therapeutics Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal Post-Traumatic Stress Disorder (PTSD) Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Post-Traumatic Stress Disorder (PTSD) Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Post-Traumatic Stress Disorder (PTSD) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Post-Traumatic Stress Disorder (PTSD) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Post-Traumatic Stress Disorder (PTSD) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Post-Traumatic Stress Disorder (PTSD) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Post-Traumatic Stress Disorder (PTSD) Therapeutics include Eli Lilly, Pfizer, GlaxoSmithKline and H. Lundbeck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Post-Traumatic Stress Disorder (PTSD) Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Post-Traumatic Stress Disorder (PTSD) Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Post-Traumatic Stress Disorder (PTSD) Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Post-Traumatic Stress Disorder (PTSD) Therapeutics Segment by Company

Eli Lilly

Pfizer

GlaxoSmithKline

H. Lundbeck

Post-Traumatic Stress Disorder (PTSD) Therapeutics Segment by Type

Antidepressants

Anxiolytics

Post-Traumatic Stress Disorder (PTSD) Therapeutics Segment by Application

Hospital

Pharmacy

Other

Post-Traumatic Stress Disorder (PTSD) Therapeutics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Post-Traumatic Stress Disorder (PTSD) Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Post-Traumatic Stress Disorder (PTSD) Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Post-Traumatic Stress Disorder (PTSD) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Post-Traumatic Stress Disorder (PTSD) Therapeutics industry.

Chapter 3: Detailed analysis of Post-Traumatic Stress Disorder (PTSD) Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Post-Traumatic Stress Disorder (PTSD) Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Antidepressants Table 3. Key Players of Anxiolytics Table 4. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Pharmacy Table 7. Key Players of Other Table 8. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Region (2021-2026) Table 11. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Region (2027-2032) Table 13. Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Trends Table 14. Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Drivers Table 15. Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Opportunities and Challenges Table 16. Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Restraints Table 17. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Company (2021-2026) Table 19. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Company Head Office and Area Served Table 21. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Company, Product Type & Application Table 22. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Type (2027-2032) Table 30. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Application (2021-2026) Table 34. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Application (2027-2032) Table 35. Eli Lilly Company Information Table 36. Eli Lilly Business Overview Table 37. Eli Lilly Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Eli Lilly Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Portfolio Table 39. Eli Lilly Recent Development Table 40. Pfizer Company Information Table 41. Pfizer Business Overview Table 42. Pfizer Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Portfolio Table 44. Pfizer Recent Development Table 45. GlaxoSmithKline Company Information Table 46. GlaxoSmithKline Business Overview Table 47. GlaxoSmithKline Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. GlaxoSmithKline Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Portfolio Table 49. GlaxoSmithKline Recent Development Table 50. H. Lundbeck Company Information Table 51. H. Lundbeck Business Overview Table 52. H. Lundbeck Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. H. Lundbeck Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Portfolio Table 54. H. Lundbeck Recent Development Table 55. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 56. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 57. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 58. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 59. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 60. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021-2026) Table 61. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2027-2032) Table 62. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 63. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 64. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 65. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 66. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 67. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021-2026) Table 68. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2027-2032) Table 69. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 70. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 71. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 72. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 73. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 74. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 75. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 76. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 77. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021-2026) Table 79. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2027-2032) Table 80. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 81. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 82. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 83. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 84. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021-2026) Table 86. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2027-2032) Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Image Figure 2. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. Antidepressants Image Figure 5. Anxiolytics Image Figure 6. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Post-Traumatic Stress Disorder (PTSD) Therapeutics Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Type (2021-2032) Figure 20. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Application (2021-2032) Figure 22. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 23. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032) Figure 24. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032) Figure 25. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2021-2032) Figure 26. United States Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 27. Canada Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 29. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 30. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032) Figure 31. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032) Figure 32. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2021-2032) Figure 33. Germany Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 34. France Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 36. Italy Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 37. Russia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 39. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032) Figure 41. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032) Figure 42. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 43. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032) Figure 44. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032) Figure 45. Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2021-2032) Figure 46. Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 50. India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 51. Australia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2021-2032) Figure 56. Brazil Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 61. UAE Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. Chile Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Antidepressants
  • Anxiolytics
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • H. Lundbeck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Antidepressants
  5. 1.2.3 Anxiolytics
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Growth Trends by Region
  13. 1.5.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region (2021-2026)
  15. 1.5.3 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Dynamics
  1. 2.1 Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Trends
  2. 2.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Drivers
  3. 2.3 Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Opportunities and Challenges
  4. 2.4 Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Company Head office and Area Served
  4. 3.4 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Company, Product Type & Application
  5. 3.5 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Post-Traumatic Stress Disorder (PTSD) Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Post-Traumatic Stress Disorder (PTSD) Therapeutics Tier 1, Tier 2, and Tier 3
4 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market by Type
  1. 4.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Share by Type (2021-2032)
5 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market by Application
  1. 5.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eli Lilly
  2. 6.1.1 Eli Lilly Company Information
  3. 6.1.2 Eli Lilly Business Overview
  4. 6.1.3 Eli Lilly Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eli Lilly Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Portfolio
  6. 6.1.5 Eli Lilly Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GlaxoSmithKline Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 H. Lundbeck
  20. 6.4.1 H. Lundbeck Company Information
  21. 6.4.2 H. Lundbeck Business Overview
  22. 6.4.3 H. Lundbeck Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 H. Lundbeck Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Portfolio
  24. 6.4.5 H. Lundbeck Recent Developments
7 North America
  1. 7.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032)
  2. 7.2 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
  3. 7.2.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
  7. 7.3.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country
  11. 7.4.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
  3. 8.2.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
  7. 8.3.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country
  11. 8.4.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032)
  2. 9.2 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
  3. 9.2.1 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
  7. 9.3.1 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032)
  2. 10.2 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
  3. 10.2.1 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
  7. 10.3.1 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country
  11. 10.4.1 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst